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ABSTRACT  
Background & aims: Most knowledge about gastrointestinal (GI)-tract dendritic cells (DC) 
relies on murine studies where CD103+ DC specialize in generating immune tolerance with 
the functionality of CD11b+/- subsets being unclear. Information about human GI-DC is 
scarce, especially regarding regional specifications. Here, we characterized human DC 
properties throughout the human colon. 
Methods: Paired proximal (right/ascending) and distal (left/descending) human colonic 
biopsies from 95 healthy subjects were taken; DC were assessed by flow cytometry and 
microbiota composition assessed by 16S rRNA gene sequencing.   
Results: Colonic DC identified were myeloid (mDC, CD11c+CD123-) and further divided 
based on CD103 and SIRPα (human analog of murine CD11b) expression. CD103-SIRPα+ 
DC were the major population and with CD103+SIRPα+ DC were CD1c+ILT3+CCR2+ 
(although CCR2 was not expressed on all CD103+SIRPα+ DC). CD103+SIRPα- DC 
constituted a minor subset that were CD141+ILT3-CCR2-. Proximal colon samples had 
higher total DC counts and fewer CD103+SIRPα+ cells. Proximal colon DC were more 
mature than distal DC with higher stimulatory capacity for CD4+CD45RA+ T-cells.  However, 
DC and DC-invoked T-cell expression of mucosal homing markers (β7, CCR9) was lower for 
proximal DC. CCR2 was expressed on circulating CD1c+, but not CD141+ mDC, and 
mediated DC recruitment by colonic culture supernatants in transwell assays. Proximal colon 
DC produced higher levels of cytokines. Mucosal microbiota profiling showed a lower 
microbiota load in the proximal colon, but with no differences in microbiota composition 
between compartments.  
Conclusions: Proximal colonic DC subsets differ from those in distal colon being more 
mature. Targeted immunotherapy using DC in T-cell mediated GI-tract inflammation may 
therefore need to reflect this immune compartmentalization. 
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Synopsis 
Intestinal dendritic cells (DC) maintain a balance between tolerance of nutrients/commensals 
and immunity against pathogens. Here, we report lower numbers of CD103+SIRPα+ DC, with 
a more mature phenotype and higher immune activity, in the proximal than in the distal 
healthy human colon. 
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INTRODUCTION 
Dendritic cells (DC), unique in their ability to generate primary T-cell mediated immune 
responses and potent promoters of secondary activity, dictate whether immune responses 
are immunogenic or tolerogenic and determine their tissue specificity1. In the gastrointestinal 
(GI) tract, DC maintain a balance between tolerance to nutrients and/or commensal 
microorganisms (the microbiota) and immunity against pathogens2-4.  
 
Human myeloid DC (mDC; CD11c+) can be divided into CD1c+ (analogous to mouse CD11b+ 
specialized for “classical presentation”) and CD141+ (analogous to mouse CD8α+ specialized 
for “cross-presentation”)5. Most current knowledge about GI-tract DC comes from mice, and 
typically from the small intestine, where CD103+ DC specialize in generating regulatory T-cell 
(T-reg) responses critical for prevention of spontaneous inflammation. Some of these 
properties appear to be maintained in the human GIT-tract6-8. Further characterization of 
murine CD103+ DC revealed that the subset co-expressing CD11b+ is unique to the GI-tract, 
with the CD103+SIRPα+ DC subset representing their human counterpart9. CD103+ DC as a 
whole are regulatory, but it is unclear whether or not specific subsets carry out distinct 
functions since CD103+CD11b+ DC can control immune tolerance [via retinaldehyde 
dehydrogenase type 2 (RALDH-2) and retinoic acid production]9-13, but can also induce Th17 
responses14; this latter property suggests some bystander effect and/or redundancy between 
subsets. CD103- DC can also generate retinoic acid and migrate to lymph nodes15. Although 
murine studies further our understanding of GI-tract DC immunology they may not always be 
relevant to humans16, 17 as, for example, RALDH-2 activity is not restricted to DC in the 
human colon but is also expressed in macrophages18.  
 
Discrepancies between human and murine DC may reflect environmental and tissue 
differences as most murine studies focus on the small bowel while human studies are 
usually of the lower GI-tract. There is therefore a need to study human intestinal DC in the 
context of different anatomical locations as murine DC subsets and function vary throughout 
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the GI-tract10, 19, 20. In agreement with this notion, we have recently showed that human large 
(colon) and small bowel (terminal ileum) DC have different properties with a lower proportion 
of DC producing pro-inflammatory cytokines in the human colon compared with the (paired) 
ileum, coupled with a higher capacity of colonic DC to generate T-reg cells21. Moreover, 
colonic and ileal DC have differential abilities to imprint homing properties on the T-cells they 
stimulate, suggesting DC compartmentalization through the human GI-tract21. These 
regional differences in human GI-tract DC are in agreement with other observations9, which 
together suggest the presence of regional immune specialization in the GI-tract (as reviewed 
recently by Mowat & Agace22).  
 
To further explore the possibility that DC change through the GI-tract we focused on the 
human colon, which is structured into different areas. After the terminal ileum (small bowel) 
the colon starts at the cecum, followed by the right or ascending colon, transverse colon, 
descending colon, sigmoid colon and finally the rectum. The right (ascending or proximal 
side) and left (descending or distal side) part of the human colon have different physiology, 
embryological origins, gene expression and epigenetic profiles, microbiota load and 
microbiota metabolic activities23-26. Moreover, proximal and distal colorectal cancers are 
recognized as different entities with proximal colorectal cancer having a lower prevalence 
but a worse prognosis27. Therefore, DC properties may not only be different between the 
small and the large bowel21, but also between different areas of the colon. Our hypothesis is 
that DC subsets, their phenotype and function change through the human GI-tract and that 
DC from different colonic compartments have different immunological properties. 
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MATERIAL AND METHODS  
Biological samples 
Colonic biopsies were obtained at colonoscopy from a total of 95 healthy controls [44.9% 
males; 57.9±12.9 years (mean ± standard deviation); age interval 28-81]. All samples were 
obtained after bowel preparation for colonoscopy, which can have an impact on mucosa-
associated microbiota composition28, 29. Samples were obtained in all cases following 
informed consent after ethical approval from the Hospital Clínico Universitario de Valladolid 
(Spain) or the Outer West London Research Ethics Committee (United Kingdom). Patients 
had been referred for colorectal cancer screening or due to rectal bleeding or changes in 
bowel transit. In all cases they had macroscopically and histologically normal intestines. 
Proximal colon refers to the right or ascending colon (closer to the small intestine) while the 
distal colon refers to the left or descending colon (closer to the rectum). Paired biopsies from 
both the distal and proximal colon were collected (maximum of 5 biopsies from each area) in 
ice-chilled complete medium [Dutch modified RPMI 1640 (Sigma-Aldrich, Dorset, UK) 
containing 100 µg/mL penicillin/streptomycin, 2 mM L-glutamine, 50 µg/mL gentamicine 
(Sigma-Aldrich) and 10% foetal calf serum (TCS cellworks, Buckingham, UK)] and 
processed within 1 hour. Gender did not affect the expression of any of the studied 
parameters. Age, however, gave a positive correlation in the proximal colon with mRNA 
expression of e-Cadherin (Pearson’s r=0.66, p-value=0.035) and microbiota load as 
determined by quantifying 16S rRNA (Pearson’s r:  -0.75, p-value=0.011).  
 
Human peripheral blood was collected from healthy volunteers with no known autoimmune 
or inflammatory diseases, allergies or malignancies following informed consent. Peripheral 
blood mononuclear cells (PBMC) were obtained by centrifugation over Ficoll-Paque PLUS 
(Amersham Biosciences, Chalfont St. Giles, UK). Some PBMC were washed twice in PBS 
containing 1 mM EDTA and 0.02% sodium azide (FACS buffer) and stained with 
fluorochrome-conjugated antibodies while others were used to enrich naïve T-cells. 
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Lamina propria DC 
Lamina propria DC were characterized by flow cytometry as previously described21, 30-32. 
Briefly, freshly obtained biopsies were incubated with Hanks balanced salt solution (HBSS) 
(Gibco BRL, Paisley, Scotland, UK) containing 1 mM DTT for 20 minutes and then in 1 mM 
EDTA solutions to remove the associated mucus/bacteria and epithelial layer, respectively. 
Lamina propia mononuclear cells (LPMC) were obtained from biopsy tissue following quick 
collagenase digestion with 1 mg/mL of collagenase D (Roche Diagnostics Ltd, Lewes, UK). 
LPMC were collected by centrifugation, washed twice in FACS buffer and stained with 
fluorochrome-conjugated antibodies. Viable DC were identified by flow cytometry within 
single live cells as CD45+ HLA-DR+ lineage (CD3 CD14 CD16 CD19 CD34)- based on 
Forward and Side scatter characteristics (Figure 1a). 
 
In some cases, LPMC were cultured overnight (37 °C,  5% CO2, high humidity) and 
subsequently enriched for DC after density-gradient centrifugation (600 g, 15 min at RT) 
using NycoPrepTM, and were then cultured with T-cells. The cells collected from the interface 
(typically 25,000-50,000 cells) have been characterized as functional colonic DC17, 21, 30-34.  
 
Antibody labelling 
LPMC and/or PBMC were stained with monoclonal antibodies for DC characterization. 
Supplementary Table 1 shows the specificity, clone fluorochrome and sources of the 
antibodies used. Cells were labelled in FACS buffer. Labelling was performed on ice and in 
the dark for 20 min. Cells were washed twice in FACS buffer, fixed with 1% 
paraformaldehyde in 0.85% saline and stored at 4 0C prior to acquisition on the flow 
cytometer (within 48 hours). Appropriate isotype-matched control antibodies were purchased 
from the same suppliers. For intracellular staining, cells were fixed with Leucoperm A 
following surface staining and permeabilized with Leucoperm B before intracellular staining.  
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Endocytic activity of DCs was determined by uptake of FITC-dextran (molecular weight 40 
kDa) (Sigma, UK) (100 µg/ml, 30 minutes at 37 °C or on ice (internal contr ol))21, 33. Surface 
staining for flow cytometry acquisition was subsequently performed as above.  
 
Proliferation assays 
CD4+ naïve T-cells were obtained from freshly isolated PBMC, suspended in MiniMACs 
buffer (PBS containing 0.5% BSA and 2 mM EDTA) and depleted of CD14, CD19, CD8, 
CD45RO and HLA-DR positive cells with immunomagnetic beads (Miltenyi Biotech, Bisley, 
UK) following the manufacturer’s instructions. CD4+ naïve T-cells were labelled with 10 µM 
5-carboxyfluorescein diacetate succinimidyl ester (CFSE, Invitrogen Ltd, UK) and cultured 
(4x105/well) for 5 days in U-bottomed 96 well microtitre plates (BD) with 0%, 1%, 2% or 3% 
enriched allogeneic colonic DC. Cells were recovered and CFSElow proliferating cells 
identified, quantified and phenotyped by flow cytometry.  
 
Culture supernatants  
Freshly obtained intestinal biopsies were immediately cultured in complete medium (1 biopsy 
per 1 ml of complete medium per well) for 24 hours after which culture media were filtered  
(0.45 µm) and cell-free supernatants preserved (-80 oC) until they were analyzed using a 
FlowCytomix Multiple Analyte Detection (Ebioscience) on a BD CantoII flow cytometer (BD), 
following the manufacturer´s instructions, for the concentration of interferon (IFN) γ 
[detection limit (DL): 0.25 pg/ml]; IFNα [DL: 4.04 pg/ml];interleukin (IL)-1β [DL: 1.80 pg/ml]; 
IL-2 [DL: 0.35 pg/ml]; IL-4 [DL: 1.22 pg/ml]; IL-5 [DL: 0.76 pg/ml]; IL-6 [DL: 4.10 pg/ml]; IL-7 
[DL: 3.18 pg/ml]; IL-9 [DL: 1.17 pg/ml]; IL-10 [DL: 2.88 pg/ml]; IL-12p70 [DL: pg/ml]; IL-13 
[DL: 0.43 pg/ml]; IL-17A [DL: 0.89 pg/ml]; IL-22 [DL: 3.98 pg/ml]; IL-23 [DL: 29.14 pg/ml]; IL-
27 [DL: 0.79 pg/ml]; leptin [DL: 34.95 pg/ml]; and tumour necrosis factor α (TNF-α) [DL: 3.10 
pg/ml]. IgA content was determined via radial immunodifussion kit (Kit IgA RID- ML, Binding 
Site, UK, DL: 8.5 mg/L) following the manufacturer’s instructions. Values below the level of 
detection were reported as being equal to that. 
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Quantitative Polymerase Chain Reaction  
Freshly obtained intestinal biopsies were immediately embedded in RNAlater (Ambion) and 
snap-frozen (-80 oC). Total RNA was isolated from each biopsy using the TRIZOL® reagent 
according to the protocol provided by the manufacturer. Reverse transcription was carried 
out by using the SuperScript® First-Strand Synthesis System for Reverse Transcriptase 
(RT)-PCR Kit (Invitrogen, Life Technologies, USA) using random hexamers. mRNA levels of 
RALDH2, CCL25, MADCAM1, e-Cadherin and GADPH (housekeeping gene), were 
measured by real-time PCR by using a LightCycler® instrument  (Roche Applied Science, 
Mannheim, Germany). Microbiota load was determined via 16S rRNA amplification. 
Reactions were performed using the FastStart SYBR Green MasterMix (Roche) with 
thermolabile Uracil DNA Glycosylase (UDG) (Roche) to prevent carry-over contamination. 
Primer sets and PCR conditions are described in Supplementary Table 2. Levels are 
expressed as the ratio molecule/GADPH in arbitrary units (U). 
 
Migration experiments 
One million fresh PBMC were placed in the upper insert of transwell culture plates and their 
capacity to migrate through 3 µm pores assessed by flow cytometry following collection of 
the cells in the lower chamber. Colonic biopsies from the proximal and distal colon were 
cultured as above in 24 well culture plates (3 biopsies per well in 1.5 ml of complete 
medium) for 18 hours after which samples were filtered (0.45 µm) and the cell-free culture 
supernatants used immediately in the lower chamber of transwell culture plates (Sigma 
Aldrich). In some experiments, the colonic supernatants were incubated (20 minutes, room 
temperature) with anti-CCL2 (1 µg/ml) prior to performing the migration experiments. In other 
cases, the lower chamber contained fresh complete medium supplemented with different 
doses of human recombinant CCL2. The addition of fluorescent counting beads (Flow-count 
Fluorospheres, Beckman Coulter, CA, USA) prior to flow cytometry acquisition allowed 
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determination of the absolute number of migrated cells into the lower chamber. Results are 
shown as a ratio compared to the basal or spontaneous migration. 
 
Flow cytometry and data analysis 
Cells were acquired on a BD Canto II (BD Biosciences) or a LSR Fortessa flow cytometer 
(BD Biosciences) and analyzed using WinList 3D 7.1 software (Verity, ME, US). The 
proportion of cells positive for a given marker was determined by reference to staining with 
an isotype-matched control antibody.  
 
Electron Microscopy 
Electron microscopy characterization of colonic DC was done as previously described21, 33, 35.  
Briefly, between 200,000–1,000,000 LPMC were fixed in 3% glutaraldehyde in 0.1 M Sodium 
phosphate buffer (SPB) pH 7.4 for up to 2 hours at room temperature and then kept at 4 0C 
until they were processed. The cells were washed in the 0.1 M pH 7.4  SPB  and embedded 
as a pellet in low gelling temperature agarose (Sigma). They were washed in 0.1 M pH 7.4 
Sodium phosphate buffer and post fixed in 1% osmium tetroxide in 0.1% pH 7.4 SPB for 1 
hour. The samples were then washed and left in distilled water overnight to remove the 
phosphate and were block stained in 2% uranyl acetate for 2-4 hours. The samples were 
washed with dH2O and dehydrated using an acetone gradient and gradually infiltrated with 
araldite resin. Araldite was changed twice over 4-8 hours, samples were embedded in the 
araldite resin and then cured for 18 hours at 65 °C . Ultrathin sections (100 nm thick) were 
cut on a Reichert-Jung Ultracut E microtome and collected on a 200 mesh copper grid. After 
staining with Reynold’s lead citrate, the grid was carbon coated and visualized using a JEOL 
1200 EX electron microscope. DC were identified as previously described33-36. DC were 
subsequently classified into mature and immature DC based on their morphology by electron 
microscopy. Immature DC were small cells with short veils relative to their size, a small  area 
of cytoplasm and heterochromatic nuclei with thick chromatin layer surrounding the nucleus 
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and chromatic dense clusters within the nucleus. In contrast, mature DC had long veiled 
projections21.  
 
Microbiota analysis 
Paired biopsies from the proximal and distal colon from a total of 19 healthy controls (9 
females, 10 males; mean age 59.7±10.2) with no known autoimmune disease and/or 
malignancies were collected. Biopsies were immediately embedded in RNAlater (Ambion) 
and snap-frozen at -80 oC. DNA was extracted using the FastDNA® SPIN Kit for Soil in 
conjunction with a Fastprep-24 machine (MP Biomedicals) following the manufacturer’s 
protocols.  
The V1-V2 regions of bacterial 16S rRNA genes were PCR amplified using Q5TM Taq 
polymerase (New England Biolabs) and Golay barcoded primers (purchased from Eurofins 
MWG Operon) MiSeq-27F (5’- AATGATACGGCGACCACCGAGATCTACACTATGGTAATT 
CCAGMGTTYGATYMTGGCTCAG-3’) and MiSeq-338R  
(5’-CAAGCAGAAGACGGCATACGAGAT-barcode-
AGTCAGTCAGAAGCTGCCTCCCGTAGGAGT-3’). Each sample included in the study was 
amplified with a 338R primer containing a unique 12-mer Golay barcode sequence. PCR 
conditions were as follows: 98 ºC for 2 mins followed by 25 cycles of 98 ºC for 30 secs, 50 
ºC for 30 secs, 72 ºC for 1 min 30 secs and then a final extension step at 72º C for 5 mins. 
Four PCR reactions per sample were carried out, which were then pooled into a single 
amplicon mix for each of the samples. PCR amplicons from each sample were then 
quantified using a Qubit 2.0 Fluorometer (Life Technologies Ltd, Invitrogen Division) and 
equimolar concentrations of each sample were added together into a final mastermix for 
sequencing on an Illumina MiSeq machine (2 x 250 bp read length). Sequence data has 
been deposited in the European Nucleotide Archive under study number ERP007146. The 
individual accession numbers for each of the biopsy samples are shown in Supplementary 
Table 3. The resulting sequence data was processed using the mothur software package, 
closely following their MiSeq SOP37. In brief, paired contigs were created from the forward 
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and reverse MiSeq reads, and all contigs shorter than 260 bp, longer than 450 bp and those 
containing any ambiguous bases or homopolymeric stretches of longer than 7 bases were 
removed. Chimeras were removed using Perseus38 as implemented in mothur. OTUs were 
generated from pre-clustered data (diffs=3) at the 97% cut-off level and then assigned a 
taxonomic classification using the RDP taxonomy provided with mothur. Diversity measures 
such as Shannon and inverse Simpson indices were calculated in mothur, where every 
sample was first subsampled down to 450 reads to ensure equal sequencing depth for these 
comparisons. Good’s coverage (an estimate of completeness of species sampling) at this 
sequencing depth was on average 93.4%. A cluster dendrogram, using the Bray Curtis 
calculator was generated in mothur, and visualised using the iTOL online resource39. 
Differences in bacterial community structure between proximal and distal colonic biopsies 
were assessed using the AMOVA, parsimony, Metastats40 and LEfSe41 tests as 
implemented in the mothur software package. 
 
Statistical analyses 
Two-tailed paired t-test, two-tailed Pearson´s correlation and two-way paired ANOVA were 
applied as explained in each section/figure legend. In the case of multiple comparisons, 
subsequent ad-hoc Bonferroni correction was applied. Microbiota data was compared using 
the AMOVA, parsimony, Metastats40 and LEfSe41 tests as implemented in the mothur 
software package42. The level of significance was fixed at p <0.05.  
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RESULTS  
Identification of human colonic DC. 
Antigen presenting cells (CD45+HLA-DRhigh) were identified within LPMC. DC discrimination 
from macrophages (Mφ) and B-cells was based on lack of expression of markers of other 
lineages (Figure 1a) as we and others have previously described17, 18, 21, 31, 32, 34. DC also had 
lower granularity as they lack Mφ vacuolar systems, aiding discrimination between DC and 
Mφ. Further analysis confirmed that DC gated in this way were CD14- and CD64- (Figure 
1b).  Additionally, in contrast to Mφ, DC up-regulated CCR7 expression following 18 hour 
culture (Figure 1b)18. Culture also induced DC maturation (Figure 1c) and these DC were 
used in functional experiments for T-cell stimulatory capacity21, 31, 33 avoiding the need for 
additional exogenous stimulation.  
  
DC numbers were significantly higher in the proximal colon (Figure 1d) with all DC in both 
compartments being mDC (CD11c+CD123-) (Figure 1e). The inability to detect non-mDC in 
human colonic biopsies was not due to sample processing and/or collagenase digestion as 
this protocol was able to detect pDC in peripheral blood mononuclear cell samples 
processed in parallel with colonic biopsies (Figure 1e). This is in agreement with recent 
observations suggesting that non-mDC in the human GI-tract are scarce or absent18, 43. 
Further analysis of colonic mDC confirmed that most were CD1c+ DC and not CD141+ DC 
(Figure 1f) with no differences between compartments.   
 
Dendritic cell subsets in the human colon 
Comparisons of DC subsets derived from the proximal and distal human colon were made 
based on CD103 and SIRPα expression9, 21 (Figure 2a). SIRPα+ DC were equally distributed 
in each compartment but there was a lower proportion of CD103+ DC in the proximal colon 
biopsies (Figure 2b), which translated into lower numbers of CD103+SIRPα+ DC (analogous 
to murine CD103+CD11b+ DC)9 at this site (Figure 2c). Further characterization revealed that 
SIRPα+ DC (both CD103+ and CD103-) were typically CD1c+ while CD103+SIRPα- were 
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CD141+ DC (Figure 2d)9, 10. CX3CR1 was virtually absent in all colonic DC (Figure 2e), but 
was expressed by macrophages17, while the GI-tract homing β7 integrin was expressed by 
the majority of colonic DC with all CD103+ DC being positive. SIRPα, which regulates 
homeostatic properties of intestinal DC44, was typically co-expressed with the inhibitory 
receptor ILT345, with no differences between CD103-SIRPα+ and CD103+SIRPα+ DC: 
CD103+SIRPα- DC were ILT3-. Conversely, ILT3- DC displayed higher expression of the 
costimulatory molecule CD40 (Figure 2e).  
 
Having characterized human colonic DC subsets, we next determined whether or not 
proximal and distal human colonic DC subsets had differences in activation/maturation and 
homing marker expression. To this end, we examined expression of CD40 (representative of 
DC maturation status) and β7 (indicative of DC gut-homing capacity) on different DC 
subsets. Given the low numbers of DC obtained from human colonic biopsies (Figure 1d), 
and that SIRPα- cells were scarce in all locations (Figures 2a-c), these markers were studied 
in CD103+SIRPα+ and CD103-SIRPα+ DC subsets (analogous to murine CD103+CD11b+ and 
CD103+CD11b- subsets, respectively)9 to ensure measurable effects. Both subsets from the 
proximal colon revealed lower β7 and higher CD40 expression compared with their distal 
counterparts (Figure 2f) suggesting that alterations in DC exist between proximal and distal 
compartments of human colon irrespective of the DC subset.  
 
CCR2 mediates DC recruitment in the colon  
We next studied the potential mechanisms that may account for blood DC recruitment by the 
human colon to see whether there was a differential recruitment capacity elicited by the 
proximal and distal sides. CCR2 mediates monocyte recruitment in the intestinal mucosa, 
although its expression may not be restricted to monocytes/macrophages as Scott et al have  
identified a novel CCR2+ DC subset within murine and human intestinal DC20. CCR2 was 
expressed by most colonic CD103-SIRPα+DC with expression being variable on 
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CD103+SIRPα+ and absent on CD103+SIRPα- DC (Figure 3a), with no differences between 
the proximal and distal side of the human colon (Figure 3b).  
 
CCR2+ APC numbers are increased in the coeliac duodenum following in vivo gluten 
challenge46, suggesting intestinal recruitment of blood precursors. We therefore 
characterized CCR2 expression on human circulating DC. Blood DC were identified within 
HLA-DR+ cells (after exclusion of CD14+CD16+CD19+ cells) and divided into subsets based 
on the expression of CD123 (pDC), CD11c/CD1c (CD1c+ mDC) and CD11c/CD141 (CD141+ 
mDC)5 (Figure 3c). Circulating CD1c+ mDC were SIRPα+ILT3+CCR2+ in contrast to 
circulating CD141+ mDC, which were SIRPα-ILT3-CCR2- (Figure 3d). Circulating CD1c+ mDC 
therefore displayed a phenotype similar to intestinal SIRPα+ DC (CD1c+ILT3+CCR2+) while 
circulating CD141+ mDC had a phenotype similar to intestinal CD103+SIRPα- DC 
(CD141c+ILT3-CCR2-) (Figures 2 and 3). These results are in agreement with recent 
observations relating intestinal SIRPα+ DC to circulating CD1c+ mDC and intestinal 
CD103+SIRPα- DC  to circulating CD141+ mDC9.  
 
The similar phenotype of intestinal SIRPα+ DC and circulating CD1c+ mDC, and expression 
of CCR2 on both DC subsets suggest that they might be recruited to the colonic mucosa in a 
CCR2 dependent manner. To explore this possibility we first confirmed that CCR2 on 
circulating mDC was functional; these cells (together with monocytes) migrated in a dose-
dependent manner towards CCL2 in transwell migration assays (Figure 3e). Finally, we 
studied whether cell-free colonic culture supernatants attracted circulating mDC. While 
circulating monocytes were not attracted by the colonic culture supernatants, DC had a 
higher migration (compared with the basal) towards distal (p-value = 0.04) and proximal (p-
value = 0.06) cell-free culture supernatants; migration was CCR2 dependent as migration 
was reduced if the culture supernatants had been previously blocked with anti-CCL2 (Figure 
3f). These results confirm that CCR2 expression is functional on circulating mDC and that it 
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mediates blood DC recruitment by the human colon. However, there was no differential 
capacity of the proximal and distal sides of the colon to recruit circulating DC.  
 
Proximal colon DC are more mature and have lower homing marker expression  
Given that there was not a differential capacity to recruit circulating DC by the proximal or 
distal human colon (Figure 3), and that DC differences between the proximal and distal 
compartments occurred in all DC subsets (Figure 2f), we next characterized in more detail 
the phenotype and function of total mDC in each compartment. 
 
As human proximal and distal colon DC expressed different levels of β7 (Figure 2f), we 
further studied the expression and potential function of gut-homing molecules β7 and 
CCR917, 31 by DC isolated from the proximal compared with the distal colon. MadCam1 
(α4β7 ligand) expression was equally distributed throughout the proximal and distal colon 
although both e-Cadherin (αEβ7 ligand) and CCL25 (CCR9 ligand) mRNA expression were 
lower in proximal colon DC (Figure 4a). Fitting with the expression patterns of their 
corresponding ligands, β7 and CCR9 expression were lower amongst DC from the proximal 
colon, with the skin- and mucosal-homing CLA and CCR10 molecules being absent (Figure 
4b).  
 
We next determined if proximal/distal colonic DC had a different maturational status, as 
suggested by higher CD40 expression displayed by proximal colon DC (Figure 2f). DC in the 
proximal colon showed higher expression of CD40, CD80 and CD86 and lower endocytic 
capacity as assessed by uptake of FITC-dextran dye, suggesting greater maturity (Figure 
4c). Lamina propria DC were also studied by electron microscopy to further analyse their 
maturation status as previously reported21, 35. There was a higher proportion of mature DC in 
the proximal colon as identified by their longer veils/dendrites relative to their size and 
euchromatic nuclei (Figure 4d) 35.  
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Proximal colonic DC are more stimulatory with lower gut-homing imprinting capacity  
Having described differences in the subsets and phenotype of proximal and distal colonic 
DC, we next studied whether these differences were reflected functionally. Colonic DC were 
enriched21, 31, 33 and co-cultured with pre-sorted CFSE-labelled allogeneic CD4+CD45RA+ T-
cells in a mixed leucocyte reaction (Figure 5a). Compared with blood DC, colonic DC display 
a low stimulatory capacity for naïve CD4+ T-cells31, which was dose dependent. However, 
distal colon DC stimulatory capacity was even lower than that of their proximal counterparts 
(Figure 5a) correlating with their lower levels of maturation markers (Figure 4c). Proximal DC 
induced a greater proportion of stimulated T-cells to produce IL-17A, with no alterations in 
production of other measured cytokines (Figure 5b). In agreement with lower homing 
marker/ligand expression in the proximal colon (Figures 4a-b), proximal DC had lower GI-
tract-homing (β7 and CCR9) and higher non-GI-tract-homing (CLA and CCR4) imprinting 
capacity for stimulated T-cells (Figure 5c). Thus, DC homing imprinting capacity may be not 
only tissue but also sub-tissue specific. 
 
Differences in the proximal and distal colonic microenvironments 
Finally, we studied potential mechanisms that may account for differences between proximal 
and distal colon DC. Given that there was no differential capacity elicited by the proximal or 
distal human colon to recruit circulating DC (Figure 3f), we next studied baseline levels of 
production of soluble immune mediators following in vitro culture of colonic biopsies. The 
proximal samples produced significantly larger amounts of IL-6, IL-22, IL-23, IL-27, leptin 
(Figure 6a) and IgA (Figure 6b). The proximal colon also had lower levels of RALDH2 mRNA 
expression (Figure 6c).  
 
We also studied the colonic microbiota, as its activity is known to change through the length 
of the human GI-tract26, 47. We found that the overall mucosa-associated microbiota load was 
higher in the distal colon (Figure 6d) although 16S rRNA gene sequencing analysis revealed 
no differences in mucosa-associated microbiota composition between the proximal and 
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distal colonic mucosae (Figure 6e). Mean Shannon Diversity Index scores, parsimony and 
AMOVA tests comparing overall diversity and bacterial community structures between 
proximal/distal colon showed no significant differences, and there were no OTUs or 
taxonomic groups associated with particular colonic regions. Inter-individual variation was 
the greatest driver of microbiota clustering patterns (Figure 6e). These results are consistent 
with many previous studies describing the predominant mucosa-associated bacterial 
community as host specific and uniformly distributed along the colon whilst being 
significantly different from the faecal/luminal community48, 49. 
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DISCUSSION. 
Here, we report that human DC subsets, phenotype and function differed between the 
proximal (right or ascending) and distal (left or descending) ends of the colon. Our results 
revealed that the proximal colon contained higher numbers of DC, which were 
immunologically more active. Thus, DC of the proximal colon showed a specific reduction of 
CD103+SIRPα+ DC and were typically more mature, with higher stimulatory capacity for T-
cells. However, balancing this increased stimulatory capacity, they had a lower potential to 
focus immune activity back to the colon, with lower expression of GI-tract homing markers 
β7 and CCR9, lower mRNA tissue expression of their ligands and lower imprinting capacity 
of these markers on T-cells they stimulate. Our results also revealed that intestinal CD103+/-
SIRPα+ DC were similar to circulating CD1c+ mDC9 and may enter the colonic mucosa in a 
CCR2 dependent manner. 
  
Human colon DC were divided into different subsets based on expression of CD103 and 
SIRPα, with the latter recently re-defined as human analogs of murine CD11b9, 21. Although 
murine CD103-CD11b+ DC can express intermediate levels of CX3CR1 (although less than 
in Mφ), CX3CR1 was absent in all human colon DC (Figure 2e)17. CD103 (αE) was co-
expressed with β7 on DC (Figure 2e) with their abundance being reduced in the proximal 
colon, in agreement with lower eCadherin mRNA expression (ligand for CD103+β7+) (Figure 
4a) in that compartment. Differential CD103+ DC distribution may account for differences in 
colonic DC function as murine CD103- DC have increased IL-17 priming capacity15 as seen 
here amongst proximal human colonic DC (Figure 5b). SIRPα was equally expressed on 
proximal and distal colon DC, rendering the proximal colon with a specific reduction of 
CD103+SIRPα+. Further analysis confirmed that colonic CD103+SIRPα+ and CD103-SIRPα+ 
DC are CD1c+ while CD103+SIRPα- are mainly CD141+, in agreement with recent 
observations relating intestinal SIRPα+ (both CD103+ and CD103-) to blood CD1c+ mDC and 
intestinal CD103+SIRPα- to blood CD141+ mDC9, 10.  Indeed, both circulating CD1c+ mDC 
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and intestinal SIRPα+ were CD1c+SIRPα+ILT3+CCR2+ while circulating CD141+ mDC and 
intestinal CD103+SIRPα- were CD141c+SIRPα-ILT3-CCR2- (Figures 2 and 3). Moreover, 
circulating CD1c+ mDC were recruited by human colonic culture supernatants in a CCR2 
dependent manner (Figure 3g). Given that DC are thought to acquire CD103 once they have 
entered the mucosa10 in a RALDH2-dependent manner50 it may be possible that circulating 
CD1c+ mDC enter the mucosa as CD103-SIRPα+ DC via CCR2 and subsequently acquire 
CD103 at the time that they lose CCR2, thus explaining its variable expression on 
CD103+SIRPα+ DC (Figure 3a-b). The lower expression of intestinal RALDH2 found in the 
proximal colon (Figure 6c) may also explain the lower proportion of CD103+ DC in that 
compartment (Figures 2b-c). The additional mechanisms responsible, however, for 
circulating CD141+ mDC recruitment by the human colon remain elusive as they do not 
express CCR2; it is likely that other chemokine receptors may be involved in their 
recruitment. 
 
Scott et al recently reported that intestinal CCR2+ DC were restricted to a fraction of CD103-
SIRPα+ DC (both human and murine) with its expression being absent on the other intestinal 
subsets20. However, in our hands CCR2 was expressed by all CD103-SIRPα+, with 
expression being variable on CD103+SIRPα+ and absent on CD103+SIRPα- DC. Further 
experiments confirmed these results using different CCR2 antibodies (Supplementary Figure 
1) potentially eliminating a technical issue. One of the reasons for this discrepancy might be 
that Scott et al20 originally described CCR2+CD103-SIRPα+ DC in murine cells and confirmed 
their presence in human samples using tissue resections from patients suffering from 
colorectal cancer. In contrast, in this study we used colonic biopsy samples from healthy 
intestines. Despite providing limited material, this use of normal tissue mitigates against the 
abnormal effects of disease and treatment that are inherent when using resected tissue, 
typically derived from patients suffering from acute GI-cancer, inflammatory bowel diseases 
and/or related diseases. All samples were obtained from patients referred to clinics due to 
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change in bowel transit, rectal bleeding and/or screening for GI-diseases although in all 
cases they had normal tissue structure and were therefore considered as normal healthy 
colonic samples. Comparisons between healthy biopsies and cancer resections would be 
required to test whether these differences in tissue source are the reason for different 
results. 
 
DC acquire a “tolerogenic” profile following exposure to soluble factors derived from 
intestinal epithelial cells50 while the pro-inflammatory milieu in inflammatory bowel disease 
may abrogate their function32, 51. The proximal colon produced significantly larger amounts of 
soluble immune mediators (Figures 6a-b) which may be responsible, at least to some extent, 
for the higher maturation status of proximal DC. RALDH2 promotes conversion of dietary 
vitamin A into retinoic acid, which mediates several of the tolerogenic properties of GI-DC 
including their capacity to generate Tregs and induce GI-tract-homing markers on T-cells 
they stimulate9-13. Given that RALDH2 expression was lower in the proximal colon (Figure 
6c), and that retinoic acid mediates acquisition of GI-tract homing markers on immune cells, 
that may also account for the lower expression of GI-tract-homing markers on DC and their 
lower imprinting capacity on T-cells they stimulate. Lower GI-tract homing 
expression/imprinting capacity of proximal DC is also coupled with lower mRNA tissue 
expression of their ligands in the proximal colon (Figure 4a). Therefore, it may be possible 
that the proximal and distal ends of the colon may use different levels of homing 
marker/ligand molecules to ensure compartmentalization of immune responses.  
 
In addition to the differences in the cytokine milieu between the proximal and distal human 
colon, a differential modulatory effect of the colonic microbiota on intestinal DC may 
contribute. Indeed, the mucosa-associated microbiota load was lower in the proximal colon 
(Figure 6d)47. Despite the similarity in mucosal microbiota composition between the proximal 
and distal colon (Figure 6e), in agreement with other observations48, 49, the metabolic output 
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of the microbiota changes through the length of the GI-tract as dietary compounds are 
gradually depleted by the microbiota as they pass through the colon26. Therefore, the 
proximal and distal colonic microbiota produce different levels of short-chain fatty acids52, 53, 
and/or other extracellular molecular effectors54, which may modulate DC properties and/or 
mucosal production of immune mediators (Figures 6a-c). Indeed, we have shown that, 
similar to human proximal/distal differences reported here, the frequency of DC was higher 
in the proximal colon of conventionally raised mice, with no differences between proximal 
and distal compartments in germ-free animals (Supplementary Figure 2). Therefore, regional 
DC differences throughout the colon might not only be influenced by the cytokine milieu itself 
but also directly or indirectly by members of the microbiota.  
 
In summary, our data suggest that human blood CD1c+ mDC are recruited by the colonic 
mucosa in a CCR2 dependent manner and confirm that DC subsets, phenotype and function 
are different between the proximal and distal human colon, and reveal the proximal colon DC 
as potentially more immunologically active than their distal counterparts. Studies of the 
immune system of the GI-tract need therefore to take account of the immune 
compartmentalization throughout its length. Future studies will address whether GI-tract-DC 
compartmentalization contributes to diseases such as subtypes of inflammatory bowel 
diseases and/or colorectal cancer where disease is anatomically restricted to different GI 
locations. Differences in disease incidence and severity could therefore be related to the 
varying immune activity of different GI-regions.  
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FIGURE LEGENDS 
Figure 1: Identification of human colonic dendritic cells. 
(a) Total antigen presenting cells [CD45+HLA-DRhigh] were identified within single viable cells 
(based on the forward/side scatter properties). DC were further discriminated from Mφ based 
on lineage marker expression (CD3,CD14,CD16,CD19,CD34). (b) In contrast to putative 
macrophages (CD45+HLA-DR+lineage+), DC (CD45+HLA-DR+lineage-) were CD64-CD14-  
and up-regulated CCR7 expression following overnight culture (blue histogram) as well as 
(c) CD40 and CD86, compared with fresh non-cultured cells (red histogram). Shaded 
histogram in Figures 1b and 1c denote isotypes (d) Percentages of DC within the total 
number of single lamina propria mononuclear cells (LPMC) were higher in the proximal 
(Prox) colon compared with the distal (Dist) (n=43). (e) Lamina propria DC were mainly 
CD11c+ myeloid DC (mDC). Lack of non-mDC in the human colon was unlikely to be due to 
sample processing as distribution of CD11c+ and CD123+ blood DC were not altered 
following DTT + EDTA + collagenase incubation (gut-protocol) of peripheral blood 
mononuclear cells. (f) Most human colonic DC were CD1c+, in contrast to CD141+DC, with 
no differences between the proximal and distal colon. Data shown in Figures 1b, 1c, and 1e 
are representative of two independent experiments. Paired t-tests were applied in Figures 
(d) and (g) and p-values <0.05 were considered significant (****p<0.0001). 
 
Figure 2: Dendritic cell subsets in the human colon. 
(a) Dendritic cells (DC) were identified as in Figure 1a and divided into subsets based on 
expression of CD103 and SIRPα. Relative proportions of DC in subsets in the proximal 
(Prox) and distal (Dist) human colon are displayed in (b) and (c). (d) CD103-SIRPα+, 
CD103+SIRPα+ and CD103+SIRPα- DC were characterized for CD1c and CD141; and also 
for (e) CX3CR1, ILT3, CD40 and β7. (f) SIRPα+CD103- and SIRPα+CD103+ DC subsets 
were identified as in Figure 2a and β7 and CD40 expression studied in biopsies from the 
proximal (blue) and distal (red) human colon compared with the isotype (shaded histogram). 
Results from panels in (d) and (e) are from at least 5 independent experiments while results 
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from panel (f) are representative of 3 independent experiments. Paired t-test (figure 2b/c) 
and paired 1-way ANOVA with Bonferroni’s ad-hoc analysis (Figure 2d/e) were applied. P-
values <0.05 were considered significant (**p<0.01; ***p<0.001; ****p<0.0001). 
 
Figure 3: CCR2 mediates blood dendritic recruitment by the human colon  
(a) CD103-SIRPα+, CD103+SIRPα+ and CD103+SIRPα- DC were identified as in Figure 2a 
and assessed for the expression of CCR2. Pooled data regarding CCR2 expression on 
different subsets and in the proximal and distal colon is shown in b). (c) Peripheral blood 
mononuclear cells (PBMC) were studied by flow cytometry. Following exclusion of CD19, 
CD14 and CD16, dendritic cells (DC) were identified within HLA-DR+ as plasmacytoid (pDC, 
CD123+) and myeloid (mDC, CD11c+). mDC were further divided into CD1c+ and CD141+. 
(d) Expression of SIRPα, ILT3 and CCR2 was determined on peripheral CD1c+ mDC, 
CD141+ mDC and pDC. (e) One million PBMC were placed in the upper insert of a transwell 
chamber and their migration towards different concentrations of CCL2 determined 3 hours 
later. Total migrated CD11c+HLA-DR+ cells were identified by flow cytometry and further 
divided into monocytes (CD14+lineage+) and DC (CD14-lineage-). (g) Migration of CCR2+ 
monocytes and DC towards cell-free biopsy culture supernatants from the proximal and 
distal human colon. DC migration was also determined with and without specific blockage of 
anti-CCL2 in the culture supernatants. Results from the transwell experiments (figures e-f) 
are displayed as ratio of migrated cells compared to the basal migration (shown as a dot 
line). Results from panels in (b) and (d) are from at least 5 independent experiments. Results 
from panel (e) summarize between 3 and 6 independent experiments per condition while 
results from panel (f) summarize 7 independent experiments. Paired t-tests were applied and 
p-values <0.05 were considered significant (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).  
 
Figure 4: Proximal colon dendritic cells have lower homing marker expression and are 
more mature 
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 (a) mRNA expression of the gut-homing ligands MADCAM1, e-Cadherin and CCL25 was 
determined on non-cultured biopsies by RT-qPCR with the results displayed in arbitrary units 
(U). (b) Dendritic cells (DC) from the proximal (Prox) and distal (Dist) human colon were 
identified as in Figure 1a and the expression of β7, CLA, CCR9 and CCR10 determined by 
flow cytometry. (c) Expression of co-stimulatory molecules (CD40, CD80, CD86) and FITC-
dextran endocytic capacity was also determined by flow cytometry. (d) Lamina propria 
dendritic cells were identified by electron microscopy in distal (Dist) and proximal (Prox) 
human colon biopsy samples. DC were characterized as immature and mature according to 
heterocromatic/euromatic nuclei and veil/dendrite extension. The percentage of mature DC 
is referred to the total number of studied DC in the proximal and distal colon. For the flow 
cytometry experiments (figures b-c) regions were set according to isotype controls (not 
shown). Histograms show paired results from several independent experiments. Paired t-
tests were applied and p-values <0.05 were considered significant (*p<0.05; **p<0.01; 
***p<0.01). 
 
Figure 5: Proximal colon dendritic cells are more stimulatory with lower gut-homing 
imprinting capacity than distal counterparts. 
(a) Four hundred thousand CFSE-labelled allogeneic CD4+CD45RA+ T-cells were cultured 
with different numbers of paired proximal (Prox) and distal (Dist) human colonic DC and their 
stimulatory capacity assessed as the percentage of proliferating T-cells (CD3+CFSElow) by 
flow cytometry. (b) Cytokine and (c) homing receptor profile of resting (non-stimulated) and 
dividing T-cells (CD3+CFSElow) stimulated with 3% Prox/Dist colonic DC. Paired two-way 
ANOVA (Figure 7a) and paired t-tests (Figure 7b/c) were applied. P-values <0.05 were 
considered significant (*p<0.05; **p<0.01). Dot-plots are representative of 8 independent 
experiments displayed in the graphics as the mean + standard error.  
 
Figure 6: Differences in the proximal and distal colonic microenvironments.  
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 (a) Fresh paired biopsies from the distal (Dist) and proximal (Prox) human colon were 
cultured for 24 hours in complete medium and the cell-free culture supernatants assessed 
for soluble cytokines/adipokines by Multiplex and (b) IgA content by radial immunodifussion. 
(c) RALDH2 mRNA expression was determined on non-cultured biopsies by RT-qPCR and 
results displayed in arbitrary units (U).  d) Microbiota load, as measured by 16S rRNA 
quantity, was determined on non-cultured biopsies from the proximal (Prox) and distal (Dist) 
human colon by RT-qPCR and results displayed in arbitrary units (U).  Paired t-tests were 
applied and p-values <0.05 were considered significant (*p<0.05). e) Cluster dendrogram, 
generated using the Bray Curtis calculator, displaying mucosal-associated microbiota 
compositional profiles in the human colonic biopsies. Each pair of samples clusters together 
in the dendrogram, illustrating the large degree of inter-individual variation rather than a 
signature proximal versus distal colonic bacterial profile. Bacterial families coloured in 
brown/yellow/orange represent the Bacteroidetes phylum, blue/grey the Firmicutes phylum, 
red/purple the Proteobacteria phylum and green the Actinobacteria phylum. Paired t-tests 
were applied in Figure a-d and p-values <0.05 were considered significant (*p<0.05; 
**p<0.01; ***p<0.001; ****p<0.0001). Results from figures a-d are displayed as mean + 
standard error of 12 independent experiments. 
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SUPPLEMENTARY MATERIALS 
Murine Experiments 
Conventionally raised and germ free (reared from germ free breeding pairs) male C57BL/6 
mice were sacrificed at 8 weeks of age and lamina propria cells isolated for flow cytometry 
analysis. Briefly; proximal and distal large intestine was chopped into small pieces and 
incubated with vigorous stirring (200 rpm) in complete media with 2 mM EDTA for 15 
minutes at 37 ºC. This was repeated, then colon pieces were recovered and incubated for 40 
minutes at 37 ºC with collagenase (type VIII, Sigma, 100 U/mL). The lamina propria cells 
were then filtered, washed and stained for flow cytometry analysis on a BD Fortessa 
instrument and Flowjo software (Treestar).  Antibodies used were: CD45 (clone 20-F11, 
Biolegend), MHCII (clone 2G9, BD), and CD11c (clone N418, Ebioscience). Staining was 
done at 4 ºC in the presence of Fc receptor block (anti-CD16/32, clone 93, Biolegend). 
Zombie AQUA (Biolegend) was used for live-dead discrimination according to 
manufacturer’s directions. All experiments were carried out with UK Home Office approval.  
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Supplementary Table 1: Antibodies and flow cytometry 
Antibody Specificity Clone Conjugate Manufacturer 
β7 FIB504  PE BD 
CCR2 K036C2 PE-Cy7 Biolegend 
 K036C2 APC Biolegend 
 48607 Alexa 647 BD 
CCR4 205410 APC R&D 
CCR7 150503 PE R&D 
CCR8 191704 APC R&D 
CCR9 248621 PE R&D 
CCR10 314305 APC R&D 
CD1c (BDCA1) AD5-8E7 FITC Miltenyi 
 AD5-8E7 PE Miltenyi 
 L161 Alexa700 Biolegend 
CD3 UCHT1 PE-Cy5 BD 
CD11c KB90 FITC Dako 
 B-Ly6 PE BD 
 
3.9 PE-Cy7 eBioscience 
 B-Ly6 BV605 BD 
 Bu15 APC-Cy7 Biolegend 
CD14 M5E2 PE BD 
 
TÜK4 PE-Cy5 Serotec 
 MΦP9  PE-CF594 BD 
CD16 3G8 PE-Cy5 BD 
CD19 HIB19 PE-Cy5 BD 
CD34 581 PE-Cy5 BD 
CD40 LOB7/6 FITC BD 
 
LOB7/6 PE BD 
CD45 HI30 PE-Cy7 BD 
 VS143 APC-Cy7 Biolegend 
 HI30 PE-Cy7 Biolegend 
 HI30 BUV395 BD 
CD64 10.1 PE-Cy5 Abcam 
 10.1 PE-Cy7 Biolegend 
CD80 L307.4 FITC BD 
 
L307.4 PE BD 
CD86 BU63 FITC Serotec 
CD103 Ber-ACT8 FITC BD 
 Ber-ACT8 PE Biolegend 
 Ber-ACT8 BV421 BD 
 Ber-ACT8 PE-Cy7 Biolegend 
CD123 6H6 PE-Cy7 eBioscience 
 7G3 BV786 BD 
CD141 (BDCA3) 501733 FITC R&D 
 1A4 BV711 BD 
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 AD5-14H12  PE Miltenyi 
CD172a (SIRPα) 602411 FITC R&D 
 602411 PE R&D 
 SE5A5 PE-Cy7 Biolegend 
CD209 (DC-SIGN) 120507 FITC R&D 
 
120507 PE R&D 
CD303 (BDCA2) AC144 FITC Miltenyi 
CLA HECA-452 APC BD 
 HECA-452 Biotin BD 
CX3CR1 528728 PE R&D 
HLA-DR G46-6 APC R&D 
 L243 BV570 Biolenged 
IFNγ 25723.11 APC BD 
IL-4 8DA-8 PE-Cy7 eBioscience 
IL-6 AS12 FITC eBioscience 
 
1936 PE R&D 
IL-10 BT-10 FITC eBioscience 
 
JES3-9D7 PE-Cy7 eBioscience 
 
JES3-19F1 APC BD 
IL-17A eBIO64DEC17 APC eBioscience 
IL-22 22URTI APC eBioscience 
 
IL22JOP PE-Cy7 eBioscience 
ILT3 293623 PE R&D 
Streptavidin not applied APC BD 
TGFβ 35409 PE R&D 
TLR2 TLR2.3 FITC Serotec 
TLR4 HTA125 FITC Serotec 
TNFα B-D9 FITC Serotec 
  Mab11 PE-Cy7 eBioscience 
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Supplementary Table 2: quantitative PCR primers 
Molecule Primers sequence Ta Primer source  
GADPH Fw 5'-GAAGGTGAAGGTCGGAGTC-3' 60 Ren et al, 20051  
 Rv 5'-GAAGATGGTGATGGGATTTC-3'    
16S rRNA Fw 5'-TTAAACTCAAAGGAATTGACGG-3' 68 Ozbek et al, 20092  
 Rv 5'-CTCACGRCACGAGCTGACGAC-3'    
RALDH2 5532957001_Roche 60 Roche  
CCL25 Fw 5'-GATAAAACCGTCGCCCTACA-3' 58 NCBI Reference Sequence: NM_005624.3  
 Rv 5'-TCCTTTGGGTCTGCACATAGC-3'    
MADCAM1 Fw 5´-CTGTACGGCCCACAAAGTCA-3´ 60 NCBI Reference Sequence: NM_130760.2  
 Rv 5´-TCTGTCACCCTGAACAGCAC-3´    
e-cadherin Fw 5´-CAGTCTCTTCTCTCACGCGT-3´ 60 NCBI Reference Sequence: NM_004360.3  
 Rv 5´-TGAGGATGGTGTAAGCGATGG-3´    
 
Primers used for quantitative PCR including primer sequence or source and annealing temperature (Ta). Primers for CCL25, MADCAM1 and e-
cadherin were designed with Primer-BLAST3 (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) using the reference sequences provided in the 
table. 
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Supplementary Table 3: ENA accession number information for each of the biopsy tissue 
sample sequencing results from the microbiota analyses. Samples marked L are from the 
left or distal colon, those marked R are from the right or proximal colon. 
Sample name Biopsy sample info ENA sample accession number 
4L Patient 4 - distal colon ERS557964 
4R Patient 4 - proximal colon ERS557965 
9L Patient 9 - distal colon ERS557966 
9R Patient 9 - proximal colon ERS557967 
10L Patient 10 - distal colon ERS557968 
10R Patient 10 - proximal colon ERS557969 
11L Patient 11 - distal colon ERS557970 
11R Patient 11 - proximal colon ERS557971 
12L Patient 12 - distal colon ERS557972 
12R Patient 12 - proximal colon ERS557973 
14L Patient 14 - distal colon ERS557974 
14R Patient 14 - proximal colon ERS557975 
15L Patient 15 - distal colon ERS557976 
15R Patient 15 - proximal colon ERS557977 
16L Patient 16 - distal colon ERS557978 
16R Patient 16 - proximal colon ERS557979 
17L Patient 17 - distal colon ERS557980 
17R Patient 17 - proximal colon ERS557981 
18L Patient 18 - distal colon ERS557982 
18R Patient 18 - proximal colon ERS557983 
19L Patient 19 - distal colon ERS557984 
19R Patient 19 - proximal colon ERS557985 
23L Patient 23 - distal colon ERS557986 
23R Patient 23 - proximal colon ERS557987 
24L Patient 24 - distal colon ERS557988 
24R Patient 24 - proximal colon ERS557989 
25L Patient 25 - distal colon ERS557990 
25R Patient 25 - proximal colon ERS557991 
28L Patient 28 - distal colon ERS557992 
28R Patient 28 - proximal colon ERS557993 
29L Patient 29 - distal colon ERS557994 
29R Patient 29 - proximal colon ERS557995 
30L Patient 30 - distal colon ERS557996 
30R Patient 30 - proximal colon ERS557997 
31L Patient 31 - distal colon ERS557998 
31R Patient 31 - proximal colon ERS557999 
32L Patient 32 - distal colon ERS558000 
32R Patient 32 - proximal colon ERS558001 
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Supplementary Figure 1:  
Dendritic cells (DC) were identified as in Figure 1a and divided into subsets based on 
expression of CD103 and SIRPα. CCR2 expression was determined in each DC subset 
using two different clones labelled with different fluorochormes: (a) clone 48607 labelled in 
Alexa 647 and b) clone K036C2 labelled in PE-Cy7. Results are representative of two 
independent experiments performed with similar results.     
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Supplementary Figure 2: Dendritic cell compartmentalization in the murine colon is 
modulated by the microbiota 
Dendritic cells (DC) from proximal (Prox) and distal (Dist) regions of the colon in 
conventional (Conv) and germ free (GF) mice were identified by flow cytometry within single 
colonic viable cells (ZombieAqua-CD45+) and mean frequencies (with SD) displayed. Results 
are representative of 2 independent experiments (n=5 mice per group in each experiment). 
One-way ANOVA with Tukey’s multiple comparisons was applied and p-values <0.05 were 
considered significant (*p<0.05, pair-wise comparisons without * were not significant). 
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Supplementary figure 2
